Sartorius Aktiengesellschaft (XTRA: SRT3)
Health Care · Life Sciences Tools & Services · DE
€250.40
+2.45% today · +24.2% 1Y
Sartorius Aktiengesellschaft (XTRA: SRT3) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $17.61B and employs 14,279 people.
Over the last twelve months the share price has gained 24.2%, trading between 187.30 and 267.70.
Tweenvest scores Sartorius Aktiengesellschaft across four factors: quality 65/100, value 56/100, growth 69/100, dividend 8/100. Its strongest factor is growth.
SRT3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.61B
- Revenue (TTM)
- $4.09B
- P/E
- —
- EPS
- —
- Dividend yield
- 0.30%
- Beta (5Y)
- 1.46
- 52-week high
- €267.70
- 52-week low
- €187.30
- Avg volume (3M)
- —
- Shares outstanding
- 69.04M
- Employees
- 14,279
- Next earnings
- —
About Sartorius Aktiengesellschaft
Sartorius AG is a global supplier of advanced bioprocess and laboratory solutions, offering a comprehensive portfolio of products and services essential for life science research and biopharmaceutical manufacturing. The company's offerings include sophisticated biosensors and detection systems, live-cell analysis platforms, and a wide array of cell culture media and reagents. Sartorius also manufactures various bioreactors, ranging from benchtop to large-scale single-use and stainless steel systems, along with their associated software applications. Its extensive filtration product line encompasses membranes, specialized filters, and diverse devices for ultrafiltration, sterile filtration, and sample preparation. Furthermore, Sartorius provides process chromatography and fluid management solutions, industrial microbiology systems, water purification units, and essential lab equipment such as weighing, pipetting, and centrifugation systems. Beyond products, the company delivers critical services including bioprocess development, protein expression, and validation. Serving sectors like life science research, biopharmaceutical manufacturing, and quality control, Sartorius was established in 1870 and is headquartered in Göttingen, Germany.
- ISIN
- DE0007165631
- Founded
- 1870
- Listed since
- Apr 28, 1999
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $234.31B | $633.41 | -0.05% |
| Danaher CorporationNYSE: DHR | $151.40B | $216.56 | +0.56% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.42B | CN¥159.25 | -1.09% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $50.96B | CHF588.40 | +0.10% |
| Agilent Technologies, Inc.NYSE: A | $43.80B | $157.65 | +1.66% |
| IQVIA Holdings Inc.NYSE: IQV | $43.04B | $263.09 | +0.60% |
| Waters CorporationNYSE: WAT | $40.69B | $423.69 | +2.30% |
Figures last refreshed Aug 18, 2026.